Plan B Media And 2 Other Asian Penny Stocks To Consider For Your Portfolio

Asian markets have been experiencing a wave of optimism, driven by resilient domestic demand in China and strong performances in Japan's technology sector. For investors exploring beyond the mainstream, penny stocks—despite their somewhat outdated moniker—continue to present intriguing opportunities. These smaller or newer companies can offer a mix of value and growth potential, particularly when backed by robust financials.

Top 10 Penny Stocks In Asia

Click here to see the full list of 962 stocks from our Asian Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Plan B Media (SET:PLANB)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Plan B Media Public Company Limited, with a market cap of THB20.98 billion, operates in Thailand offering advertising media production services through its subsidiaries.

Operations: The company generates revenue primarily through its out-of-home media segment, contributing THB10.12 billion, and its engagement marketing segment, which adds THB2.12 billion.

Market Cap: THB20.98B

Plan B Media, with a market cap of THB20.98 billion, has demonstrated robust financial health, being debt-free and maintaining strong asset coverage over both short-term (THB5.5 billion) and long-term liabilities (THB2.8 billion). The company's earnings have grown significantly by 37.6% annually over the past five years, although recent growth has slowed to 5.2%. Despite this deceleration, analysts expect further stock price appreciation of 31%. The board's experience (7.5 years average tenure) and management's seasoned leadership contribute positively to its stability in the dynamic advertising media sector in Thailand.

• Take a closer look at Plan B Media's potential here in our financial health report.
• Gain insights into Plan B Media's outlook and expected performance with our report on the company's earnings estimates.

PSG Corporation (SET:PSGC)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: PSG Corporation Public Company Limited operates in turnkey engineering procurement construction (EPC) and large-scale construction projects in Thailand and Laos, with a market cap of THB14.24 billion.

Operations: The company generates revenue from its Plant and Building Construction segment, amounting to THB2.72 billion.

Market Cap: THB14.24B

PSG Corporation, with a market cap of THB14.24 billion, operates in the EPC and large-scale construction sectors in Thailand and Laos. Despite being debt-free and having high-quality earnings, PSGC's financial performance has faced challenges recently. The company's net profit margins have decreased from 40.5% to 13.9%, alongside negative earnings growth of -73.8% over the past year, diverging from industry trends. Short-term assets exceed liabilities significantly (THB4.3 billion vs THB638.8 million), providing some financial stability despite volatility in share price and lower return on equity at 7.8%. Recent board changes reflect ongoing corporate adjustments amidst these dynamics.

• Jump into the full analysis health report here for a deeper understanding of PSG Corporation.
• Review our historical performance report to gain insights into PSG Corporation's track record.

Shanghai Hile Bio-Technology (SHSE:603718)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China with a market cap of approximately CN¥2.50 billion.

Operations: Shanghai Hile Bio-Technology Co., Ltd. has not reported any specific revenue segments.

Market Cap: CN¥2.5B

Shanghai Hile Bio-Technology Co., Ltd. has faced financial challenges, with a net loss of CN¥311.44 million for 2025 compared to a net income the previous year, and sales declining to CN¥187.87 million from CN¥271.04 million. Its short-term assets of CN¥590.5 million comfortably cover both short-term and long-term liabilities, indicating some financial stability despite recent volatility in earnings performance and share price movements following its removal from the S&P Global BMI Index. The company's experienced board and management team may help navigate these difficulties as it seeks to improve profitability amidst ongoing operational hurdles.

• Click here and access our complete financial health analysis report to understand the dynamics of Shanghai Hile Bio-Technology.
• Gain insights into Shanghai Hile Bio-Technology's historical outcomes by reviewing our past performance report.

Taking Advantage

• Gain an insight into the universe of 962 Asian Penny Stocks by clicking here.
• Contemplating Other Strategies? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 15 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com